GVALX Mutual Fund

GVALX Mutual Fund

NAV$16.19
See how much of GVALX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jun 30, 2026

Net Assets
$31M
Expense Ratio
0.75%
Dividend Yield (Current)
10.06%
Holdings
275
Inception Date
Dec 31, 2015
Fund Family
Gotham Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+16.60%
1 Year+22.13%
3 Year+19.14%
5 Year+10.38%
10 Year+12.81%

Asset Allocation

Stocks: 99.21%
Cash: 0.79%
See how much of GVALX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LRCXLam Research Corp2.70%
CATCaterpillar Inc1.72%
MRKMerck & Company Inc1.54%
QCOMQualcomm Inc.1.32%
KOCoca Cola Co.1.32%
Top 10 Concentration: 14.46%Report Date: Jun 30, 2026
Download all 275 holdings for GVALX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
10.06%
Frequency
Annually
Latest Distribution
$2.87
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

GVALX Mutual Fund Overview

GVALX Mutual Fund (Gotham Large Value Fund Institutional Class) is managed by Gotham Funds with $31.0M in net assets. GVALX expense ratio is 0.75%, holding 275 positions across sectors including Information Technology, Industrials, Health Care. Inception date: 2015-12-31.

GVALX performance shows a YTD return of 16.60%. The 1-year return is 22.13% and the 5-year return is 10.38%. GVALX dividend yield stands at 10.06%, paid annually.

GVALX top holdings include Lam Research Corp (2.7%), Caterpillar Inc (1.7%), Merck & Company Inc (1.5%), Qualcomm Inc. (1.3%), Coca Cola Co. (1.3%). Go to all GVALX holdings, GVALX sectors, or GVALX dividends.

GVALX can be compared against other funds. Use GVALX overlap to find shared positions, or GVALX vs another fund for a side-by-side view. GVALX alternatives are available via the screener, along with tax-loss harvesting opportunities.